Tenaya Therapeutics, Inc.
TNYA
$1.42
$0.1612.69%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 17.49% | 15.10% | 10.44% | 8.18% | 6.56% |
| Total Depreciation and Amortization | 3.41% | 3.01% | -2.52% | -0.73% | 1.30% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -14.80% | -3.49% | 5.89% | 37.00% | 41.43% |
| Change in Net Operating Assets | 36.02% | -59.29% | -40.42% | -75,760.00% | -424.79% |
| Cash from Operations | 21.35% | 15.42% | 11.34% | 8.55% | 8.35% |
| Capital Expenditure | 12.13% | 28.11% | 17.27% | 25.91% | 81.76% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4.52% | -22.96% | -95.68% | -137.44% | -55.53% |
| Cash from Investing | -4.28% | -22.79% | -97.68% | -140.07% | -53.40% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 6.19% | -0.16% | 949.43% | -41.54% | -41.58% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | 100.00% |
| Cash from Financing | 5.20% | -0.16% | 1,079.28% | -41.18% | -41.22% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 126.03% | 55.28% | 15.59% | -254.74% | -139.11% |